Abbott Laboratories (Brazil) Today
| ABTT34 Stock | BRL 56.22 0.06 0.11% |
Performance6 of 100
| Odds Of DistressLess than 9
|
Abbott Laboratories is trading at 56.22 as of the 22nd of November 2024, a 0.11 percent down since the beginning of the trading day. The stock's open price was 56.28. Abbott Laboratories has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat modest performance during the last 90 days. Equity ratings for Abbott Laboratories are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of May 2024 and ending today, the 22nd of November 2024. Click here to learn more.
Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. The company was founded in 1888 and is based in North Chicago, Illinois. ABBOTT DRN operates under Medical Devices classification in Brazil and is traded on Sao Paolo Stock Exchange. The company has 20.92 B outstanding shares. More on Abbott Laboratories
Moving together with Abbott Stock
| 0.65 | MDTC34 | Medtronic plc | PairCorr |
| 0.85 | B1SX34 | Boston Scientific | PairCorr |
| 0.63 | E1WL34 | Edwards Lifesciences | PairCorr |
Moving against Abbott Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Abbott Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Abbott Laboratories' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Abbott Laboratories or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Robert Ford |
| Business Concentration | Medical Devices, Healthcare (View all Sectors) |
Abbott Laboratories (ABTT34) is traded on Sao Paulo Exchange in Brazil and employs 115,000 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 1 T. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Abbott Laboratories's market, we take the total number of its shares issued and multiply it by Abbott Laboratories's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Abbott Laboratories operates under Healthcare sector and is part of Medical Devices industry. The entity has 20.92 B outstanding shares.
Abbott Laboratories has accumulated about 8.37 B in cash with 10.53 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.18.
Check Abbott Laboratories Probability Of Bankruptcy
Abbott Laboratories Risk Profiles
Although Abbott Laboratories' alpha and beta are two of the key measurements used to evaluate Abbott Laboratories' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.04 | |||
| Semi Deviation | 1.2 | |||
| Standard Deviation | 1.56 | |||
| Variance | 2.42 |
Abbott Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Abbott Laboratories without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Transaction History Now
Transaction HistoryView history of all your transactions and understand their impact on performance |
| All Next | Launch Module |
Abbott Laboratories Corporate Directors
| Samuel Scott | Independent Director | Profile | |
| Nancy McKinstry | Independent Director | Profile | |
| Phebe Novakovic | Independent Director | Profile | |
| Roxanne Austin | Independent Director | Profile |
Additional Information and Resources on Investing in Abbott Stock
When determining whether Abbott Laboratories is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Abbott Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Abbott Laboratories Stock. Highlighted below are key reports to facilitate an investment decision about Abbott Laboratories Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abbott Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade Abbott Stock refer to our How to Trade Abbott Stock guide.You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..